1. Market Research
  2. > Pharmaceutical Market Trends
  3. > The Brazilian Pharmaceutical & Health Sector

The Brazilian Pharmaceutical & Health Sector

  • July 2015
  • -
  • FALKE Information Services
  • -
  • 37 pages

The Brazilian pharmaceutical sector is estimated to have grown at an average annual rate of 14.2% between 2007 and 2015, reaching revenues of US$ 23 billion. Generics have gained considerable relevance and currently represent 26% of the market compared to merely 12% in 2007. Exports only represent about 7% of sales and the sector’s trade balance has remained negative, reaching a deficit of US$ 6.6 billion in 2015. Families’ spend with health increased 114% over the past 8 years but hospital beds per inhabitant have dropped below the minimum threshold recommended by the World Health Organization. United States and European Union remain the main players in the global pharmaceutical foreign trade.

This report analyses the subject market in Brazil, its main products and services, main players’ performance and the Brazilian pharmaceutical market in the global scenario.

Table Of Contents

The Brazilian Pharmaceutical and Health Sector
1. Overview of the Brazilian pharmaceutical sector
Brief history of the Brazilian pharmaceutical sector
Supply chain diagram for the pharmaceutical sector in Brazil
Pharmaceutical revenues breakdown into branded and generics and share on national GDP (2007-2015)
Pharmaceutical sales breakdown into branded and generics and price per box (2007-2015)
Evolution of registered drugs and generics share in the world and selected regions (2007-2015)
Pharmaceuticals exports and trade balance evolution in Brazil (2007-2015)
Pharmaceuticals exports and trade balance evolution in the Mercosur (2007-2015)
Use of capacity and sales seasonality for pharmaceuticals in Brazil (2007-2015)
Employment and sales volume evolution in the pharmaceutical sector in Brazil (2005-2015)
Pharmaceuticals price evolution and comparison to standard inflation in Brazil (2000-2015)

2. Overview of the hospital and health sector in Brazil
Consumption of health goods and services and share on national GDP in Brazil (2007-2015)
Geographic breakdown of families' absolute and relative spend on drugs per income level (2013)
Geographic breakdown of hospital beds and share of public hospitals across regions (2007-2015)
Hospital beds per 1,000 inhabitants across geographic regions and WHO threshold (1996-2015)
Hospitalisation, level of occupation and laboratory exams in Brazil (2007-2015)
Hospital beds and number of surgeries, and surgery breakdown per size (2007-2015)
Hospital revenue breakdown per service and according to payment source (2007-2015)
Revenue vs. hospitalisation per bed bubble chart according to revenue in private hospitals (2014)

3. Main players in the Brazilian pharmaceutical sector
Main financial figures for the top 12 pharmaceutical groups in Brazil (2014)
Ebitda and exports share on revenues for the top 10 pharmaceutical companies in Brazil (2014)
Ebitda vs. ROE bubble chart according to revenue for the top 10 pharmaceutical groups in Brazil (2014)
Brief history of the top 4 pharmaceutical conglomerates in Brazil

4. The Brazilian pharmaceutical sector in the world
Global pharmaceutical sales ranking, consumption evolution and forecast (2007-2017)
Turnover ranking for pharmaceutical companies in the world and RandD spend (2014)
Top 13 pharmaceutical exporters in the world (2001 vs. 2009 vs. 2013)
Pharmaceutical exports and imports in Brazil and 14 selected countries (2013)
Geographic breakdown of global consumption of pharmaceuticals (2012 vs. 2017)
Pharmaceutical sales forecast and breakdown according to world regions, branded and generics (2012-2017)
Geographic breakdown of RandD investments for pharmaceuticals compared to other industries (2013)
Setbacks: hidden costs in the purchase of pharmaceuticals in Brazil and other selected countries

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation

  • $ 6995
  • Industry report
  • January 2017
  • by GBI Research

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation Summary Melanoma is a type of cancer that begins in the ...

North America Vision Care Market Outlook to 2022

North America Vision Care Market Outlook to 2022

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

North America Vision Care Market Outlook to 2022 Summary GlobalData’s new report, "North America Vision Care Market Outlook to 2022", provides key market data on the North America Vision Care market. ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.